
Max Healthcare (MAXHEALTH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
19.1B
Gross Profit
15.0B
78.56%
Operating Income
4.1B
21.52%
Net Income
3.2B
16.70%
Balance Sheet Metrics
Total Assets
152.1B
Total Liabilities
58.3B
Shareholders Equity
93.8B
Debt to Equity
0.62
Cash Flow Metrics
Revenue & Profitability Trend
Max Healthcare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 70.3B | 53.1B | 44.9B | 38.8B | 24.8B |
Cost of Goods Sold | 14.8B | 11.2B | 9.2B | 9.2B | 5.9B |
Gross Profit | 55.5B | 41.9B | 35.7B | 29.6B | 18.9B |
Gross Margin % | 79.0% | 78.9% | 79.5% | 76.2% | 76.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 14.7B | 13.8B | 11.8B | 9.5B | 6.4B |
Other Operating Expenses | 10.5B | 4.0B | 3.4B | 2.7B | 2.1B |
Total Operating Expenses | 25.3B | 17.8B | 15.3B | 12.2B | 8.4B |
Operating Income | 14.9B | 13.0B | 10.5B | 7.9B | 2.9B |
Operating Margin % | 21.2% | 24.4% | 23.3% | 20.4% | 11.6% |
Non-Operating Items | |||||
Interest Income | 1.2B | 1.6B | 1.1B | 750.9M | 767.3M |
Interest Expense | 1.7B | 445.6M | 713.2M | 900.1M | 1.7B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 14.1B | 13.7B | 10.6B | 7.4B | -686.5M |
Income Tax | 3.3B | 3.1B | -397.9M | 1.3B | 458.5M |
Effective Tax Rate % | 23.5% | 22.5% | -3.7% | 18.1% | 0.0% |
Net Income | 10.8B | 10.6B | 11.0B | 6.1B | -1.4B |
Net Margin % | 15.3% | 19.9% | 24.6% | 15.6% | -5.5% |
Key Metrics | |||||
EBITDA | 20.0B | 16.9B | 13.8B | 10.8B | 5.5B |
EPS (Basic) | ₹11.07 | ₹10.89 | ₹11.38 | ₹6.25 | ₹-1.59 |
EPS (Diluted) | ₹11.01 | ₹10.84 | ₹11.36 | ₹6.24 | ₹-1.59 |
Basic Shares Outstanding | 971887986 | 971566374 | 970063788 | 967465373 | 863195968 |
Diluted Shares Outstanding | 971887986 | 971566374 | 970063788 | 967465373 | 863195968 |
Income Statement Trend
Max Healthcare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 6.6B | 9.8B | 13.7B | 3.1B | 6.3B |
Short-term Investments | 784.5M | 1.6B | 12.4B | 1.7B | 2.0M |
Accounts Receivable | 6.9B | 4.6B | 3.4B | 3.9B | 3.7B |
Inventory | 1.1B | 798.4M | 762.3M | 613.6M | 538.0M |
Other Current Assets | 486.5M | 191.2M | 163.3M | 215.8M | 179.1M |
Total Current Assets | 15.9B | 17.1B | 19.4B | 10.0B | 11.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 54.6B | 13.5B | 9.1B | 7.8B | 6.9B |
Goodwill | 95.2B | 85.4B | 75.2B | 75.7B | 72.4B |
Intangible Assets | 25.6B | 26.3B | 26.1B | 26.6B | 23.3B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 3.7B | 3.6B | 100.0K | -100.0K | 2.2B |
Total Non-Current Assets | 136.2B | 102.9B | 81.6B | 81.9B | 74.2B |
Total Assets | 152.1B | 120.0B | 101.0B | 91.9B | 85.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.1B | 6.8B | 5.4B | 4.4B | 4.4B |
Short-term Debt | 2.4B | 1.2B | 904.7M | 1.2B | 886.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.6B | 60.1M | 60.1M | 146.6M | 645.4M |
Total Current Liabilities | 18.1B | 12.5B | 10.5B | 7.6B | 7.8B |
Non-Current Liabilities | |||||
Long-term Debt | 27.7B | 13.9B | 8.2B | 10.2B | 12.4B |
Deferred Tax Liabilities | 6.5B | 5.1B | 4.4B | 6.8B | 5.8B |
Other Non-Current Liabilities | 2.3B | 2.6B | 2.4B | 2.4B | 2.4B |
Total Non-Current Liabilities | 40.2B | 23.4B | 16.5B | 21.5B | 21.3B |
Total Liabilities | 58.3B | 35.9B | 26.9B | 29.1B | 29.1B |
Equity | |||||
Common Stock | 9.7B | 9.7B | 9.7B | 9.7B | 9.7B |
Retained Earnings | - | 21.9B | 12.3B | 1.4B | -4.6B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 93.8B | 84.1B | 74.1B | 62.8B | 56.4B |
Key Metrics | |||||
Total Debt | 30.1B | 15.1B | 9.1B | 11.4B | 13.3B |
Working Capital | -2.2B | 4.6B | 9.0B | 2.4B | 3.5B |
Balance Sheet Composition
Max Healthcare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 14.1B | 13.7B | 10.6B | 7.4B | -686.5M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 545.9M | 496.2M | 343.6M | 339.3M | 265.1M |
Working Capital Changes | -2.4B | -1.3B | 496.6M | -905.9M | 931.0M |
Operating Cash Flow | 13.0B | 11.9B | 11.2B | 7.1B | 3.6B |
Investing Activities | |||||
Capital Expenditures | -9.6B | -7.7B | -3.3B | -5.5B | -1.2B |
Acquisitions | -6.2B | -6.3B | -4.8M | -1.1B | 0 |
Investment Purchases | -7.7M | -12.6M | -968.1M | -1.7B | 0 |
Investment Sales | - | - | 997.1M | - | - |
Investing Cash Flow | -14.8B | -14.4B | -1.4B | -8.3B | -1.2B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -1.5B | -970.1M | - | - | - |
Debt Issuance | 13.5B | 6.3B | 70.7M | 365.6M | 7.4B |
Debt Repayment | -10.5B | -5.6B | -1.4B | -2.5B | -8.3B |
Financing Cash Flow | 1.5B | -179.4M | -1.6B | -1.9B | 3.9B |
Free Cash Flow | 4.9B | 3.4B | 9.5B | 1.9B | -5.6M |
Net Change in Cash | -292.2M | -2.7B | 8.3B | -3.1B | 6.3B |
Cash Flow Trend
Max Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
115.26
Forward P/E
52.98
Price to Book
13.09
Price to Sales
17.47
PEG Ratio
69.74
Profitability Ratios
Profit Margin
15.31%
Operating Margin
23.51%
Return on Equity
12.10%
Return on Assets
7.02%
Financial Health
Current Ratio
0.88
Debt to Equity
32.09
Beta
0.33
Per Share Data
EPS (TTM)
₹10.96
Book Value per Share
₹96.50
Revenue per Share
₹72.31
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
maxhealth | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.0T | 72.09 | 12.70 | 18.85% | 6.63% | 90.89 |
Fortis Healthcare | 677.5B | 78.10 | 7.60 | 8.44% | 10.73% | 26.99 |
Global Health | 372.6B | 69.59 | 11.01 | 15.30% | 13.04% | 21.19 |
Narayana Hrudayalaya | 358.6B | 45.78 | 9.89 | 21.78% | 13.82% | 66.93 |
Aster DM Healthcare | 302.1B | 92.34 | 8.47 | 147.28% | 7.55% | 55.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.